AU2002217841A1 - Neuroactive steroid derivatives and methods of use - Google Patents

Neuroactive steroid derivatives and methods of use

Info

Publication number
AU2002217841A1
AU2002217841A1 AU2002217841A AU1784102A AU2002217841A1 AU 2002217841 A1 AU2002217841 A1 AU 2002217841A1 AU 2002217841 A AU2002217841 A AU 2002217841A AU 1784102 A AU1784102 A AU 1784102A AU 2002217841 A1 AU2002217841 A1 AU 2002217841A1
Authority
AU
Australia
Prior art keywords
methods
neuroactive steroid
steroid derivatives
derivatives
neuroactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217841A
Inventor
David H. Farb
Terrell T. Gibbs
David W. Johnson
Robert Christopher Pierce
Ghazaleh Sadri-Vakili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Scion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scion Pharmaceuticals Inc filed Critical Scion Pharmaceuticals Inc
Publication of AU2002217841A1 publication Critical patent/AU2002217841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002217841A 2000-11-06 2001-11-06 Neuroactive steroid derivatives and methods of use Abandoned AU2002217841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24614400P 2000-11-06 2000-11-06
US60/246,144 2000-11-06
PCT/US2001/043975 WO2002036128A1 (en) 2000-11-06 2001-11-06 Neuroactive steroid derivatives and methods of use

Publications (1)

Publication Number Publication Date
AU2002217841A1 true AU2002217841A1 (en) 2002-05-15

Family

ID=22929474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217841A Abandoned AU2002217841A1 (en) 2000-11-06 2001-11-06 Neuroactive steroid derivatives and methods of use

Country Status (3)

Country Link
EP (1) EP1347763A4 (en)
AU (1) AU2002217841A1 (en)
WO (1) WO2002036128A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850023B1 (en) * 2003-01-17 2007-04-06 Mapreg DRUGS FOR THE NERVOUS SYSTEM
US9339508B2 (en) 2003-01-17 2016-05-17 Mapreg Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury
US7576073B2 (en) 2004-05-28 2009-08-18 UNIVERSITé LAVAL Combined therapy for the treatment of parkinson's disease
US20090074677A1 (en) * 2007-01-08 2009-03-19 Duke University Neuroactive steroid compositions and methods of use therefor
CZ303037B6 (en) * 2009-05-28 2012-03-07 Ústav organické chemie a biochemie, Akademie ved CR, v. v. i. Pregnanolone derivatives substituted in position 3 alpha, process for their preparation and use
AU2011206864B2 (en) 2010-01-15 2013-12-19 Suzhou Neupharma Co., Ltd. Certain chemical entities, compositions, and methods
US9018197B2 (en) 2010-08-28 2015-04-28 Suzhou Neupharma Co. Ltd. Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use
EP3453714B1 (en) 2011-02-02 2020-11-04 Suzhou Neupharma Co., Ltd Cardenolide and bufadienolide 3-carbonate and 3-carbamate derivatives for the treatment of cancer and compositions thereof
CZ201181A3 (en) * 2011-02-15 2012-09-12 Ústav organické chemie a biochemie Akademie ved CR, v.v.i. Pregnanolone derivatives substituted in position 3alpha with cationic group, process of their preparation, their use and composition containing them
HUE031390T2 (en) * 2011-05-20 2017-07-28 Inserm - Inst Nat De La Sante Et De La Rech Medicale Antagonists of cb1 receptor
CN109354598A (en) 2012-04-29 2019-02-19 润新生物公司 Chemical entity, pharmaceutical composition and cancer treatment method
NZ708086A (en) 2012-11-28 2020-04-24 Inst Nat Sante Rech Med 3-(4’-substituted)-benzyl-ether derivatives of pregnenolone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474763A (en) * 1982-07-07 1984-10-02 Lubowe Irwin I Skin preparation
JP2746041B2 (en) * 1992-02-14 1998-04-28 三菱化学株式会社 New steroid derivatives
EP0840612A1 (en) * 1995-07-24 1998-05-13 Trustees Of Boston University Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
DE60041773D1 (en) * 1999-08-31 2009-04-23 Univ Boston THE EFFECT OF STEROIDS ON NDMA RECEPTORS IS BASED ON THE COMPOSITION OF SUB-UNITS

Also Published As

Publication number Publication date
EP1347763A1 (en) 2003-10-01
WO2002036128A9 (en) 2003-11-13
EP1347763A4 (en) 2005-10-12
WO2002036128A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2468401A (en) Underreamer and method of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU7101000A (en) Microfabrication methods and devices
AU6333499A (en) Use of nanoscale sterols and sterol esters
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2001255169A1 (en) Carbon nanostructures and methods of preparation
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU7350600A (en) Inpsb/inas bjt device and method of making
AU2001255199A1 (en) Ceramide derivatives and method of use
AU2001273125A1 (en) Combinations of bisphosphonates, estrogenic agents and optionally estrogens
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU2001273074A1 (en) Combinations of ssri and estrogenic agents
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2001271785A1 (en) Combinations of statins, estrogenic agents and optionally estrogens
AU2002217841A1 (en) Neuroactive steroid derivatives and methods of use
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AUPQ429399A0 (en) Oxidized apolipoproteins and methods of use
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2003279800A1 (en) Sulfatases and methods of use thereof